PharmaVoice ٢٩ يناير ٢٠٢٦ Eli Lilly, BioAge chase NLRP3 inhibitors with ‘pipeline in a pill’ potential
PharmaVoice ٢٧ يناير ٢٠٢٦ A potential gene therapy for heart failure is an approach decades in the making
PharmaVoice ٢٠ يناير ٢٠٢٦ Texas, N. Carolina, Ohio, Pennsylvania — where pharma manufacturing investments have surged
PharmaVoice ١٥ يناير ٢٠٢٦ It’s crunch time for US biopharma M&A. Can drugmakers strike deals despite persisting anxieties?
PharmaVoice ١٤ يناير ٢٠٢٦ Lilly, Novo test direct-to-employer approach that could cut out PBMs and lower costs